This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Prove 3 is for relapsers and non responders, so there is good reason not to make us suffer through 48 weeks of placebo when there is no chance of SVR. In addition, there is enough data available now to predict a positive response based on the viral load at week 4 and 12. I think Vertex is trying to make it easier on us if the prognosis as poor.
If it's as good as indicated then 12 should be plenty of time to clear as Phase III is designed primarily for protocol (12 with all 3 and 12 with just 2 dropping the VX) for the new go forward tx strategy.
I agree on not continuing if we're not responding as the Consensus protocol may be the better route (a bit tougher) for those that are not responding to 12 weeks with all 3 drugs. And agree that likely it may be Vertex 'having mercy' on those that are not going to respond to stop earlier than later. But I sure hope that I get to continue after my 4 weeks (done in the 6th week) but understand also that a new blood test has been added to 6 week point to finalize a decision if one is 'close'.
I'm a little nervous now.
I don't think safety is part of this issue.
Thanks for that. I think it's great that they are being sensitive to limiting your exposure to TPV in Prove 3 if it doesn't look like you're going to respond. It just surprised me that they would back it all the way up to making the decision at Week 4 and not Week 12.
I see your posts elsewhere on these boards. Hope you're doing well and get to SVR!